Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.
Shah NR, Bhor M, Latremouille-Viau D, Kumar Sharma V, Puckrein GA, Gagnon-Sanschagrin P, Khare A, Kumar Singh M, Serra E, Davidson M, Xu L, Guerin A. Shah NR, et al. J Med Econ. 2020 Nov;23(11):1345-1355. doi: 10.1080/13696998.2020.1813144. Epub 2020 Sep 9. J Med Econ. 2020. PMID: 32815766 Free article.
Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States.
Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A, Wu EQ, Patwardhan P. Atallah EL, et al. Among authors: latremouille viau d. J Health Econ Outcomes Res. 2022 Aug 4;9(2):19-29. doi: 10.36469/001c.36975. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35979528 Free PMC article.
Chronic Myeloid Leukemia: Part II-Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective.
Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A. Atallah EL, et al. Among authors: latremouille viau d. J Health Econ Outcomes Res. 2022 Aug 4;9(2):30-36. doi: 10.36469/001c.36976. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35979529 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36163937
Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United States.
Sharma P, Falk GW, Bhor M, Ozbay AB, Latremouille-Viau D, Guerin A, Shi S, Elvekrog MM, Limburg P. Sharma P, et al. Among authors: latremouille viau d. J Health Econ Outcomes Res. 2023 Mar 3;10(1):51-58. doi: 10.36469/001c.68191. eCollection 2023. J Health Econ Outcomes Res. 2023. PMID: 36883055 Free PMC article.
Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States.
Sharma P, Falk GW, Bhor M, Ozbay AB, Latremouille-Viau D, Guérin A, Shi S, Elvekrog MM, Limburg P. Sharma P, et al. Among authors: latremouille viau d. Medicine (Baltimore). 2023 Mar 24;102(12):e33072. doi: 10.1097/MD.0000000000033072. Medicine (Baltimore). 2023. PMID: 36961193 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36164170